tiprankstipranks
Indoco Remedies Limited (IN:INDOCO)
:INDOCO
India Market
Want to see IN:INDOCO full AI Analyst Report?

Indoco Remedies Limited (INDOCO) Price & Analysis

0 Followers

INDOCO Stock Chart & Stats

₹242.00
₹4.72(1.94%)
At close: 4:00 PM EDT
₹242.00
₹4.72(1.94%)

Bulls Say, Bears Say

Bulls Say
Diversified Revenue StreamsA multi-pronged business model (branded domestic formulations, API sales, exports to regulated markets and CDMO services) provides durable revenue diversification. This reduces single-market dependence and supports resilience from product-cycle and geographic mix shifts over 2–6 months.
In-house Manufacturing & R&DOwning manufacturing and R&D is a structural competitive asset: it enables control over quality, faster product development, regulatory filings for exports, and the ability to win contract manufacturing work. These capabilities support sustainable margins and entry into regulated markets.
Positive Revenue Growth And Solid Gross MarginConsistent top-line growth with a ~41% gross margin indicates underlying demand and a product mix that preserves manufacturing economics. If operating costs are controlled, this structural revenue traction and healthy gross margin can translate to durable operating recovery over the medium term.
Bears Say
Consecutive Net LossesTwo straight years of net losses erode retained earnings and investor capital and drive negative ROE (~-10.5%). Persistent negative profitability undermines reinvestment ability, reduces buffer for downturns, and makes sustainable recovery dependent on meaningful margin or revenue inflection.
Rising LeverageA marked increase in leverage materially reduces financial flexibility and raises fixed interest burdens. With weak profitability, higher debt raises refinancing and solvency risk, constrains strategic investment, and makes the firm more vulnerable to adverse cash-flow or regulatory shocks.
Deeply Negative Free Cash FlowSustained deeply negative free cash flow despite positive but small operating cash inflows implies capital spending or working-capital drains not covered by operations. This forces reliance on external financing, limits strategic options, and elevates medium-term execution and liquidity risk.

Indoco Remedies Limited News

INDOCO FAQ

What was Indoco Remedies Limited’s price range in the past 12 months?
Indoco Remedies Limited lowest stock price was ₹163.70 and its highest was ₹332.15 in the past 12 months.
    What is Indoco Remedies Limited’s market cap?
    Indoco Remedies Limited’s market cap is ₹20.27B.
      When is Indoco Remedies Limited’s upcoming earnings report date?
      Indoco Remedies Limited’s upcoming earnings report date is Nov 05, 2026 which is in 92 days.
        How were Indoco Remedies Limited’s earnings last quarter?
        Indoco Remedies Limited released its earnings results on Jul 28, 2026. The company reported ₹7.1 earnings per share for the quarter, beating the consensus estimate of -₹3.6 by ₹10.7.
          Is Indoco Remedies Limited overvalued?
          According to Wall Street analysts Indoco Remedies Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Indoco Remedies Limited pay dividends?
            Indoco Remedies Limited pays a Annually dividend of ₹0.2 which represents an annual dividend yield of 0.09%. See more information on Indoco Remedies Limited dividends here
              What is Indoco Remedies Limited’s EPS estimate?
              Indoco Remedies Limited’s EPS estimate is 0.9.
                How many shares outstanding does Indoco Remedies Limited have?
                Indoco Remedies Limited has 92,303,604 shares outstanding.
                  What happened to Indoco Remedies Limited’s price movement after its last earnings report?
                  Indoco Remedies Limited reported an EPS of ₹7.1 in its last earnings report, beating expectations of -₹3.6. Following the earnings report the stock price went down -7.931%.
                    Which hedge fund is a major shareholder of Indoco Remedies Limited?
                    Currently, no hedge funds are holding shares in IN:INDOCO
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Indoco Remedies Limited

                      Indoco Remedies Limited, an Indian pharmaceutical company founded in Mumbai in 1945 (originally known as Indo Continental Trading Company), operates globally, manufacturing and distributing a broad spectrum of finished drug formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses diverse therapeutic areas: Respiratory conditions: with offerings like Karvol Plus, Febrex Plus, and Tuspel. Oral and dental care (stomatologicals): including Sensodent-K, Sensoform Toothpaste, the Rexidin series, and Snowdent. Gastrointestinal ailments: featuring products such as Carmicide, Cyclopam, and Nosic. Pain relief/analgesics: exemplified by Lignox and T-lac. Ophthalmic and otic solutions: comprising items like Renolen, Dexoren – S, and the Mofloren range. Vitamins, minerals, and nutritional supplements: such as Methycal, MCBM DHA, and Apispur. Urological treatments: including Carmicide and Cital. Dermatological preparations: like Cloben G and Scabex. Anti-infective agents: represented by ATM. Blood-related therapies: such as Hemsyl. Gynecological health products: including MCBM 69 and D Chiro. Anti-haemorrhoidal treatments: with Spear. Beyond its pharmaceutical manufacturing, Indoco Remedies provides comprehensive analytical services. These include impurity profiling, particle size analysis, heavy metal analysis, polymorphism studies, compatibility and stability assessments (like extractables/leachables and lyophilization), and advanced chromatographic method development and validation. Furthermore, the company offers a suite of engineering and project management services. This covers architectural and structural design, mechanical and electrical engineering, lighting solutions, control system integration, piping design, data transfer systems, and holistic project and construction management for process facilities. Indoco Remedies serves a wide range of medical professionals, from general practitioners and pediatricians to specialized consultants like dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists.

                      Indoco Remedies Limited (INDOCO) Earnings & Revenues

                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Alembic Pharmaceuticals Limited
                      Hikal Limited
                      Morepen Laboratories Limited
                      Solara Active Pharma Sciences Ltd.
                      Unichem Laboratories Limited
                      Popular Stocks